We are live on ! Find out more
LP

Lexington Partners Portfolio holdings

AUM $134M
1-Year Est. Return 1.93%
This Fund
S&P 500
This Quarter Est. Return
-10.89%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
AUM
$194M
AUM Growth
-$26.4M
Cap. Flow
+$1.53M
Cap. Flow %
0.79%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$1.53M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 62.5%
2 Financials 20.8%
3 Technology 12.33%
4 Real Estate 3.64%
5 Healthcare 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDP icon
1
Keurig Dr Pepper
KDP
$42.3B
$106M 54.86%
3,001,248
DNB
2
DELISTED
Dun & Bradstreet
DNB
$40.3M 20.8%
2,679,211
DNUT icon
3
Krispy Kreme
DNUT
$569M
$14.8M 7.64%
1,087,353
SWI
4
DELISTED
SolarWinds Corporation Common Stock
SWI
$12.7M 6.56%
1,239,867
NABL icon
5
N-able
NABL
$695M
$11.2M 5.76%
1,239,867
COMP icon
6
Compass
COMP
$10.2B
$7.04M 3.64%
1,951,155
NGM
7
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1.42M 0.73%
+110,428
New +$1.53M

Similar funds

Lexington Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Lexington Partners held 7 positions worth $194M, down 12% from $220M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Lexington Partners's Q2 2022 filing shows 1 new position. Its largest new stake was NGM Biopharmaceuticals, Inc. Common Stock: 110,428 shares worth $1.42M.

By sector, the portfolio is most concentrated in Consumer Staples at 63% of assets, up from 59% a quarter earlier, followed by Financials and Technology.

  • Lexington Partners's largest Q2 2022 buy was NGM Biopharmaceuticals, Inc. Common Stock: 110,428 shares worth $1.42M.
  • Lexington Partners's ten largest holdings make up 100% of its $194M portfolio in Q2 2022.
  • Lexington Partners opened 1 new position and closed 0 in Q2 2022.
  • Lexington Partners's portfolio value fell 12% quarter-over-quarter to $194M.

Based on Lexington Partners's 13F filing for Q2 2022, filed 12 Aug 2022.